BSX Revenue Flow
Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.
- 2026-06-30: Revenue $5.44B; Cost of revenue $1.59B; Selling, general and administrative $1.80B; Operating expenses $2.67B.
- 2026-03-31: Revenue $5.20B; Cost of revenue $1.59B; Selling, general and administrative $1.78B; Operating expenses $2.51B.
- 2025-12-31: Revenue $5.29B*; Cost of revenue $1.61B*; Selling, general and administrative $1.83B*; Operating expenses $2.85B*.
- 2025-09-30: Revenue $5.07B; Cost of revenue $1.52B; Selling, general and administrative $1.74B; Operating expenses $2.49B.
Product or service
Separate filed amounts; connecting flows are not established. Components and totals may overlap.
Geography
Separate filed amounts; connecting flows are not established. Components and totals may overlap.
Segment
Separate filed amounts; connecting flows are not established. Components and totals may overlap.
Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.
Historical revenue and expense breakdown
Revenue and expense 3 month
| Period end | Revenue | Cost of revenue | Selling, general and administrative | Operating expenses | Income tax | Net income |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5.44B | $1.59B | $1.80B | $2.67B | $155.00M | (m) |
| 2026-03-31 | $5.20B | $1.59B | $1.78B | $2.51B | -$176.00M | (m) |
| 2025-12-31 | $5.29B* | $1.61B* | $1.83B* | $2.85B* | $30.00M* | (m) |
| 2025-09-30 | $5.07B | $1.52B | $1.74B | $2.49B | $183.00M | (m) |
| 2025-06-30 | $5.06B | $1.64B | $1.72B | $2.60B | $146.00M | (m) |
| 2025-03-31 | $4.66B | $1.45B | $1.60B | $2.29B | $133.00M | (m) |
| 2024-09-30 | $4.21B | $1.31B | $1.56B | $2.16B | $200.00M | (m) |
| 2024-06-30 | $4.12B | $1.27B | $1.45B | $2.33B | $98.00M | (m) |
| 2024-03-31 | $3.86B | $1.21B | $1.36B | $1.97B | $115.00M | (m) |
| 2023-09-30 | $3.53B | $1.10B | $1.24B | $1.73B | $105.00M | (m) |
| 2023-06-30 | $3.60B | $1.06B | $1.35B | $2.03B | $156.00M | (m) |
| 2023-03-31 | $3.39B | $1.04B | $1.22B | $1.80B | $131.00M | (m) |
| 2022-09-30 | $3.17B | $979.00M | $1.13B | $1.83B | $57.00M | (m) |
| 2022-06-30 | $3.24B | $1.01B | $1.17B | $1.81B | $85.00M | (m) |
| 2022-03-31 | $3.03B | $955.00M | $1.06B | $1.60B | $45.00M | (m) |
| 2021-09-30 | $2.93B | $900.00M | $1.07B | $1.65B | $64.00M | (m) |
| 2021-06-30 | $3.08B | $945.00M | $1.12B | $1.87B | -$37.00M | (m) |
| 2021-03-31 | $2.75B | $894.00M | $1.02B | $1.49B | -$16.00M | (m) |
| 2020-09-30 | $2.66B | $869.00M | $984.00M | $2.00B | -$72.00M | (m) |
| 2020-06-30 | $2.00B | $791.00M | $798.00M | $1.28B | -$33.00M | (m) |
| 2020-03-31 | $2.54B | $806.00M | $978.00M | $1.59B | $12.00M | (m) |
| 2019-09-30 | $2.71B | $777.00M | $1.01B | $1.55B | -$35.00M | (m) |
| 2019-06-30 | $2.63B | $758.00M | $968.00M | $1.49B | -$9.00M | (m) |
| 2019-03-31 | $2.49B | $730.00M | $869.00M | $1.22B | $33.00M | (m) |
| 2018-09-30 | $2.39B | $672.00M | $870.00M | $1.33B | $24.00M | (m) |
| 2018-06-30 | $2.49B | $739.00M | $886.00M | $1.36B | -$209.00M | (m) |
| 2018-03-31 | $2.38B | $672.00M | $860.00M | $1.30B | $26.00M | (m) |
| 2017-09-30 | $2.22B | $637.00M | $800.00M | $1.21B | $26.00M | (m) |
| 2017-06-30 | $2.26B | $632.00M | $815.00M | $1.40B | -$55.00M | (m) |
| 2017-03-31 | $2.16B | $650.00M | $794.00M | $1.15B | $15.00M | (m) |
| 2016-09-30 | (m) | $594.00M | $772.00M | $1.16B | $29.00M | (m) |
| 2016-06-30 | (m) | $639.00M | $779.00M | $1.82B | -$190.00M | (m) |
| 2016-03-31 | (m) | $573.00M | $716.00M | $1.10B | $26.00M | (m) |
| 2015-09-30 | (m) | $539.00M | $729.00M | $1.65B | -$169.00M | (m) |
| 2015-06-30 | (m) | $540.00M | $700.00M | $1.08B | $3.00M | (m) |
| 2015-03-31 | $1.77B | $520.00M | $668.00M | $1.22B | -$50.00M | (m) |
| 2014-09-30 | (m) | $550.00M | $741.00M | $1.23B | -$40.00M | (m) |
| 2014-06-30 | (m) | $563.00M | $743.00M | $1.38B | -$108.00M | (m) |
| 2014-03-31 | (m) | $537.00M | $666.00M | $1.04B | $13.00M | (m) |
| 2013-09-30 | (m) | $510.00M | $658.00M | $1.12B | -$35.00M | (m) |
| 2013-06-30 | (m) | $530.00M | $661.00M | $1.06B | $22.00M | (m) |
| 2013-03-31 | (m) | $578.00M | $631.00M | $1.51B | -$40.00M | (m) |
| 2012-09-30 | $1.74B | $558.00M | $589.00M | $1.77B | $1.00M | (m) |
| 2012-06-30 | $1.83B | $578.00M | $648.00M | $4.84B | -$40.00M | (m) |
| 2012-03-31 | $1.87B | $631.00M | $659.00M | $1.04B | $10.00M | (m) |
| 2011-09-30 | $1.87B | $680.00M | $629.00M | $1.02B | -$31.00M | (m) |
| 2011-06-30 | $1.98B | $688.00M | $642.00M | $1.05B | $12.00M | (m) |
| 2011-03-31 | $1.93B | $631.00M | $596.00M | $972.00M | $227.00M | (m) |
| 2010-12-31 | $2.00B | (m) | (m) | (m) | (m) | (m) |
| 2010-09-30 | $1.92B | $623.00M | $634.00M | $1.04B | -$27.00M | $190.00M |
| 2010-06-30 | $1.93B | $654.00M | $634.00M | $1.04B | $21.00M | $98.00M |
| 2010-03-31 | $1.96B | $663.00M | $628.00M | $2.78B | $14.00M | (m) |
| 2009-12-31 | $2.08B | (m) | (m) | (m) | (m) | (m) |
| 2009-09-30 | $2.02B | $629.00M | $665.00M | $1.34B | $50.00M | -$94.00M |
| 2009-06-30 | $2.07B | $630.00M | $671.00M | $1.17B | $22.00M | $158.00M |
| 2009-03-31 | $2.01B | $607.00M | $651.00M | $1.39B | -$84.00M | (m) |
| 2008-09-30 | $1.98B | $655.00M | $610.00M | $1.29B | -$6.00M | (m) |
| 2008-06-30 | $2.02B | $604.00M | $655.00M | $1.12B | $2.00M | (m) |
Revenue and expense 6 month
| Period end | Revenue | Cost of revenue | Selling, general and administrative | Operating expenses | Income tax | Net income |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10.65B | $3.18B | $3.58B | $5.18B | -$21.00M | (m) |
| 2025-06-30 | $9.72B | $3.09B | $3.31B | $4.89B | $279.00M | (m) |
| 2024-06-30 | $7.98B | $2.48B | $2.81B | $4.30B | $213.00M | (m) |
| 2023-06-30 | $6.99B | $2.10B | $2.57B | $3.83B | $287.00M | (m) |
| 2022-06-30 | $6.27B | $1.97B | $2.23B | $3.42B | $131.00M | (m) |
| 2021-06-30 | $5.83B | $1.84B | $2.14B | $3.36B | -$53.00M | (m) |
| 2020-06-30 | $4.55B | $1.60B | $1.78B | $2.88B | -$22.00M | (m) |
| 2019-06-30 | $5.12B | $1.49B | $1.84B | $2.71B | $24.00M | (m) |
| 2018-06-30 | $4.87B | $1.41B | $1.75B | $2.66B | -$183.00M | (m) |
| 2017-06-30 | $4.42B | $1.28B | $1.61B | $2.55B | -$40.00M | (m) |
| 2016-06-30 | (m) | $1.21B | $1.50B | $2.92B | -$164.00M | (m) |
| 2015-06-30 | (m) | $1.06B | $1.37B | $2.31B | -$47.00M | (m) |
| 2014-06-30 | $3.65B | $1.10B | $1.41B | $2.42B | -$95.00M | (m) |
| 2013-06-30 | (m) | $1.11B | $1.29B | $2.57B | -$18.00M | (m) |
| 2012-06-30 | $3.69B | $1.21B | $1.31B | $5.88B | -$30.00M | (m) |
| 2011-06-30 | $3.90B | $1.32B | $1.24B | $2.02B | $239.00M | (m) |
| 2010-06-30 | $3.89B | $1.32B | $1.26B | $3.83B | $36.00M | -$1.49B |
| 2009-06-30 | $4.08B | $1.24B | $1.32B | $2.56B | -$62.00M | $145.00M |
| 2008-06-30 | $4.07B | $1.19B | $1.31B | $2.00B | $142.00M | (m) |
Revenue and expense 9 month
| Period end | Revenue | Cost of revenue | Selling, general and administrative | Operating expenses | Income tax | Net income |
|---|---|---|---|---|---|---|
| 2025-09-30 | $14.79B | $4.61B | $5.05B | $7.39B | $463.00M | (m) |
| 2024-09-30 | $12.19B | $3.79B | $4.37B | $6.47B | $413.00M | (m) |
| 2023-09-30 | $10.52B | $3.20B | $3.81B | $5.56B | $392.00M | (m) |
| 2022-09-30 | $9.44B | $2.94B | $3.36B | $5.25B | $188.00M | (m) |
| 2021-09-30 | $8.76B | $2.74B | $3.21B | $5.00B | $10.00M | (m) |
| 2020-09-30 | $7.20B | $2.46B | $2.76B | $4.87B | -$94.00M | (m) |
| 2019-09-30 | $7.83B | $2.27B | $2.85B | $4.26B | -$11.00M | (m) |
| 2018-09-30 | $7.26B | $2.08B | $2.62B | $3.99B | -$159.00M | (m) |
| 2017-09-30 | $6.64B | $1.92B | $2.41B | $3.75B | -$13.00M | (m) |
| 2016-09-30 | (m) | $1.80B | $2.27B | $4.08B | -$135.00M | (m) |
| 2015-09-30 | (m) | $1.60B | $2.10B | $3.96B | -$215.00M | (m) |
| 2014-09-30 | (m) | $1.65B | $2.15B | $3.65B | -$135.00M | (m) |
| 2013-09-30 | (m) | $1.62B | $1.95B | $3.69B | -$53.00M | (m) |
| 2012-09-30 | $5.43B | $1.77B | $1.90B | $7.65B | -$30.00M | (m) |
| 2011-09-30 | $5.77B | $2.00B | $1.87B | $3.04B | $208.00M | (m) |
| 2010-09-30 | $5.80B | $1.94B | $1.90B | $4.87B | $9.00M | -$1.30B |
| 2009-09-30 | $6.11B | $1.87B | $1.99B | $3.90B | -$12.00M | $51.00M |
| 2008-09-30 | $6.05B | $1.84B | $1.93B | $3.30B | $136.00M | (m) |
Revenue and expense 12 month
| Period end | Revenue | Cost of revenue | Selling, general and administrative | Operating expenses | Income tax |
|---|---|---|---|---|---|
| 2025-12-31 | $20.07B | $6.22B | $6.89B | $10.24B | $493.00M |
| 2024-12-31 | $16.75B | $5.26B | $5.98B | $8.89B | $436.00M |
| 2023-12-31 | $14.24B | $4.34B | $5.19B | $7.55B | $393.00M |
| 2022-12-31 | $12.68B | $3.96B | $4.52B | $7.08B | $443.00M |
| 2021-12-31 | $11.89B | $3.71B | $4.36B | $6.98B | $36.00M |
| 2020-12-31 | $9.91B | $3.46B | $3.79B | $6.53B | $2.00M |
| 2019-12-31 | $10.73B | $3.12B | $3.94B | $6.10B | -$4.01B |
| 2018-12-31 | $9.82B | $2.81B | $3.57B | $5.50B | -$249.00M |
| 2017-12-31 | $9.05B | $2.59B | $3.29B | $5.17B | $828.00M |
| 2016-12-31 | $8.39B | $2.42B | $3.10B | $5.51B | -$170.00M |
| 2015-12-31 | $7.48B | $2.17B | $2.87B | $5.59B | -$411.00M |
| 2014-12-31 | (m) | $2.21B | $2.90B | $5.47B | -$390.00M |
| 2013-12-31 | (m) | $2.17B | $2.67B | $4.85B | -$102.00M |
| 2012-12-31 | (m) | $2.35B | $2.54B | $8.77B | -$39.00M |
| 2011-12-31 | $7.62B | $2.66B | $2.49B | $4.06B | $201.00M |
| 2010-12-31 | $7.81B | $2.60B | $2.58B | $5.86B | $2.00M |
| 2009-12-31 | $8.19B | $2.58B | $2.63B | $6.51B | -$283.00M |
| 2008-12-31 | $8.05B | $2.47B | $2.59B | $7.09B | $5.00M |
| 2007-12-31 | $8.36B | $2.34B | $2.91B | $6.03B | -$74.00M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |